- Home
- LENZ vs BOW Comparison
LENZ vs BOW Comparison
Compare LENZ & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- BOW
- Stock Information
- Founded
- LENZ 2019
- BOW 2020
- Country
- LENZ United States
- BOW United States
- Employees
- LENZ N/A
- BOW N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- BOW Property-Casualty Insurers
- Sector
- LENZ Health Care
- BOW Finance
- Exchange
- LENZ Nasdaq
- BOW Nasdaq
- Market Cap
- LENZ 852.0M
- BOW 848.1M
- IPO Year
- LENZ 2021
- BOW 2024
- Fundamental
- Price
- LENZ $31.63
- BOW $27.29
- Analyst Decision
- LENZ Strong Buy
- BOW Buy
- Analyst Count
- LENZ 4
- BOW 6
- Target Price
- LENZ $56.25
- BOW $36.17
- AVG Volume (30 Days)
- LENZ 1.3M
- BOW 238.5K
- Earning Date
- LENZ 11-05-2025
- BOW 11-04-2025
- Dividend Yield
- LENZ N/A
- BOW N/A
- EPS Growth
- LENZ N/A
- BOW 42.10
- EPS
- LENZ N/A
- BOW 1.53
- Revenue
- LENZ $17,500,000.00
- BOW $519,241,000.00
- Revenue This Year
- LENZ N/A
- BOW $17.36
- Revenue Next Year
- LENZ $285.82
- BOW $23.19
- P/E Ratio
- LENZ N/A
- BOW $17.91
- Revenue Growth
- LENZ N/A
- BOW 33.44
- 52 Week Low
- LENZ $16.54
- BOW $23.50
- 52 Week High
- LENZ $50.40
- BOW $42.29
- Technical
- Relative Strength Index (RSI)
- LENZ 55.37
- BOW 55.79
- Support Level
- LENZ $27.44
- BOW $26.28
- Resistance Level
- LENZ $26.81
- BOW $27.79
- Average True Range (ATR)
- LENZ 2.41
- BOW 0.87
- MACD
- LENZ 1.12
- BOW 0.18
- Stochastic Oscillator
- LENZ 99.43
- BOW 73.46
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About BOW Bowhead Specialty Holdings Inc. Common Stock
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.